Out-of-pocket costs for drugs for neurologic diseases such as MS, Parkinson's and Alzheimer's disease are climbing sharply, according to research led by Amanda Gusovsky, of Ohio State University in ...

Alzheimer’s disease or dementia care is valued at $346.6 billion; contributing nearly 40% of the total family caregiving valuation.

Florida Rep. Maria Elvira Salazar (R) has introduced two bills that provide retirement security for family caregivers.

Sinaptica Therapeutics, Inc., a clinical-stage company leading the development of a new class of personalized neuromodulation therapeutics to treat Al ...

The results in Alzheimer's come a few months after Lexeo also reported encouraging data with its gene therapy for ...

A landmark study featured in the Alzheimer’s and Dementia journal in 2020 identified what it deems the "single most important ...

Even making changes to what you eat could significantly reduce your risk of the condition. A noteworthy study, published in the Alzheimer’s and Dementia journal in 2020, pinpointed what it considers ...

As the world of neurodegenerative disease drug development continues to be roiled by controversies, one company has taken a ...

This artificial intelligence-powered avatar was developed to offer a lifeline for people living with Alzheimer’s and dementia ...

Rhode Island’s colleges and universities are at the leading edge of science and technology, addressing critical issues that shape our world every day.

Researchers have discovered that methazolamide, a glaucoma drug, can clear tau protein build-up in the brain, a key factor in ...

Howard Gleckman discusses the reality of long-term care today. Christine Benz: Hi, I’m Christine Benz from Morningstar and welcome to the How to Retire podcast. It’s a companion to my book, which is ...